Expertise that comes from specialization

With an estimated 350 million people worldwide suffering from one of 7,000 diseases classified as rare, Saol considers expanding treatment options to be critical. We are greatly aware of the needs that exist within this diverse patient population, and are aggressively exploring ways to help these underserved patient populations. Currently, we are investigating our potential involvement in a range of therapeutic categories in addition to our current concentration on neuroscience. 

For us at Saol, rare diseases and the patient populations they impact are our focus, and we are fully committed each and every day to helping them find answers for their conditions. We believe that by specializing in specific therapeutic categories, Saol can bring deep knowledge and innovation to the treatment of conditions that typically are underserved. By bringing products to market that either improve efficacy, tolerability, or ease of use, we can make a significant impact on patients’ lives.